PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Markitects, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Sun Biomedical Nominated for Zloty OTIS Confidence Award - Polish consumers name their most trusted pharmaceutical products. Sun Biomedical Nominated for Zloty OTIS Confidence Award, for their most popular product, OraLine® Saliva Drug Screen device - SunBiomed.com
Sun Biomedical Nominated for Zloty OTIS Confidence Award

 

NewswireToday - /newswire/ - Blackwood, NJ, United States, 2008/12/15 - Polish consumers name their most trusted pharmaceutical products. Sun Biomedical Nominated for Zloty OTIS Confidence Award, for their most popular product, OraLine® Saliva Drug Screen device - SunBiomed.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Sun Biomedical Laboratories Inc. (SBL) was recently nominated for the Zloty OTIS Prize, awarded by Polish consumers to their most trusted pharmaceutical products. The company’s popular OraLine® Saliva Drug Screen device is the product being nominated. OraLine is used to test the presence of drug abuse on the spot and get accurate results within ten minutes.

The “Zloty OTIS” or Gold Otis prizes are awarded for products that have the greatest trust among Polish consumers. The award has been active since 2004. Hundreds of products representing thirty-eight therapeutic categories from almost one hundred pharmaceutical companies take part in the contest. Zloty OTIS administrators require that the “Confidence Prize” fulfills three functions: educational, social and consumer.
“We’d like to thank our distribution partner in Poland, TOP-MED, for supporting our nomination for this prestigious award,” stated Jack Kerins, CEO Sun Biomedical Laboratories. “We’ve been working with TOP-MED and are very pleased that OraLine has already gained so much popularity with Polish consumers.”

Manufactured in the U.S. from premium membranes, the OraLine Saliva Drug Screen is an extremely accurate immunoassay designed to detect the presence of several illicit drugs in human saliva at levels equal to or greater than the cut-off level indicated. Drugs detected include: marijuana, cocaine, methamphetamines, and opiates/morphine/heroin. The company has recently released an advanced OraLine8 version at the Medica 2008 conference last month.

About Sun Biomedical Laboratories, Inc.

Sun Biomedical Laboratories, Inc. produces both urine and saliva based drugs of abuse testing devices at its main facility in Blackwood, New Jersey. The company has established an industry benchmark with the most sensitive saliva drugs of abuse testing device available on the market today. The company also has a portfolio of research into the use of saliva as a diagnostic medium for other disease states that provide the foundation for continued research and development and a broader portfolio of point of care testing devices. The Company, founded in 1993, is an operating unit of Sun Biomedical Limited, a public company listed on the Australian Stock Exchange (ASX) under the symbol "SBN". For more information about Sun Biomedical Laboratories and its products, contact us at 888-440-8388.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Markitects, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Sun Biomedical Nominated for Zloty OTIS Confidence Award

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jack Kerins, CEO - SunBiomed.com 
856-401-1080 jkerins[.]sunbiomed.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Markitects, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Markitects, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Explorers Vacation Club





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)